# PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1

> **NCT06738680** · — · NOT_YET_RECRUITING · sponsor: **University Hospital, Brest** · enrollment: 120 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** LAFOV system (an innovative, latest-generation system) scan

## Key facts

- **NCT ID:** NCT06738680
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-30
- **Primary completion:** 2026-01-30
- **Final completion:** 2026-11-02
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06738680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06738680, "PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06738680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*